BCTX
BriaCell Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · CA
$3.38
−0.59%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-154.1%
Return on equity
-136.9%
Return on assets
-160.6%
Return on invested capital
0.00x
Asset turnover
-$36.9M
Cash from operations
$2.62
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Apr 1, 2026